ModelEdge

20/20 GeneSystems, Inc.
0001139685
Filing Type1-U
Filing Date11/20/2025
Updated11/21/25, 1:16 PM

Filing

1-U
Earnings Release

Exhibits

1-UCurrent Report for Regulation A
EX1U-3 HLDRS RTSWARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON NOVEMBER 17, 2025
EX1U-6 MAT CTRCTSECURITIES PURCHASE AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLC
EX1U-6 MAT CTRCTSECURED CONVERTIBLE PROMISSORY NOTE ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON NOVEMBER 17, 2025
EX1U-6 MAT CTRCTSECURITY AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLC
EX1U-6 MAT CTRCTINTELLECTUAL PROPERTY SECURITY AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLC
EX1U-6 MAT CTRCTSECURITIES PURCHASE AGREEMENT, DATED NOVEMBER 17, 2025, BETWEEN 20/20 BIOLABS, INC. AND STREETERVILLE CAPITAL, LLC
EX1U-6 MAT CTRCTPLACEMENT AGENCY AGREEMENT, DATED NOVEMBER 18, 2025, BETWEEN 20/20 BIOLABS, INC. AND MAXIM GROUP LLC